FLOT1 and cancer: IGF-1-dependent depalmitoylation and repalmitoylation of flotillin-1 regulate the tyrosine kinase activation of plasma membrane-localized IGF-1R. When flotillin-1's palmitoylation function is impaired, preventing its turnover, cancer cell proliferation after IGF-1R signaling activation is eliminated.